ClinicalTrials.Veeva

Menu

BACTERIUM: Study for a Machine-learning-based Model to Predict Bloodstream Infections

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

Infection, Bloodstream

Treatments

Drug: antibiotic treatments

Study type

Observational

Funder types

Other

Identifiers

NCT05876598
BACTERIUM-4407

Details and patient eligibility

About

An increase of healthcare-associated infections caused by multidrug- resistant organisms (MRDO) is currently observed. One of the main causes of the emergence of a MDRO infection is an overuse of antibiotics. Therefore, saving useless antibiotic treatment is currently a priority from a public health point of view. The evaluation of the risk of having a bloodstream infection will allow both activating faster treatment decisions (when the risk is significantly high) or to save useless resources in terms of diagnostic tests and treatments, also limiting the potential for side effects (when the risk is significantly low).

Enrollment

5,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. adult patients hospitalized at the Gemelli Polyclinic Foundation
  2. having at least one performed blood culture
  3. starting an antibiotic therapy

Exclusion criteria

  1. blood cultures with contaminants
  2. <18 years old
  3. died after less than 48 hours from blood cultures positivity

Trial contacts and locations

1

Loading...

Central trial contact

rita murri

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems